What does Sunshine Biopharma, Inc. do?
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS…
What is Sunshine Biopharma, Inc.'s P/E and P/B ratio?
Sunshine Biopharma, Inc. has a P/E ratio of -0.0 and a P/B ratio of 0.09.
What is Sunshine Biopharma, Inc.'s debt-to-equity ratio?
Sunshine Biopharma, Inc. has a debt-to-equity ratio of 0.02.
How much does Sunshine Biopharma, Inc. owe compared with what it owns?
Sunshine Biopharma, Inc. owes $0.18 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Sunshine Biopharma, Inc.'s Positivity rank?
Sunshine Biopharma, Inc. is ranked #780 of 6,774 companies globally and #131 of 4,000 in United States on PositoAI, with a Positivity Score of 23,752.
Does Sunshine Biopharma, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Sunshine Biopharma, Inc. has no active red flags. It has 1 yellow flag (PosiYellow stress signals, 4/10 points): Annual report filed late (NT 10-K).
Where can I read the latest news about Sunshine Biopharma, Inc.?
Recent headlines about Sunshine Biopharma, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Sunshine Biopharma, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Sunshine Biopharma, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.